Natco Pharma Limited

Natco Pharma Limited (NATCOPHARM) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

Ask AI

Key metrics

Price as of 2026-09-03

Stock price
₹838.30
Market cap
15,014 Cr
Stock P/E
19.3
P/B
1.63
Dividend yield
0.6%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales1,031 Cr759 Cr1,068 Cr1,363 Cr1,371 Cr475 Cr1,221 Cr1,329 Cr1,363 Cr647 Cr739 Cr735 Cr
Operating expenses (approx.)573 Cr491 Cr571 Cr558 Cr567 Cr436 Cr673 Cr758 Cr784 Cr489 Cr612 Cr549 Cr
EBITDA458 Cr268 Cr497 Cr805 Cr804 Cr39 Cr548 Cr571 Cr579 Cr159 Cr128 Cr187 Cr
OPM %44.4%35.3%46.6%59.1%58.7%8.2%44.9%43.0%42.5%24.5%17.3%25.4%
Other income29 Cr37 Cr42 Cr48 Cr64 Cr176 Cr66 Cr62 Cr100 Cr58 Cr78 Cr59 Cr
Interest4 Cr5 Cr6 Cr5 Cr4 Cr4 Cr10 Cr3 Cr13 Cr10 Cr11 Cr13 Cr
Depreciation44 Cr44 Cr56 Cr44 Cr46 Cr47 Cr98 Cr58 Cr52 Cr46 Cr50 Cr47 Cr
Profit before tax440 Cr256 Cr478 Cr804 Cr818 Cr164 Cr506 Cr572 Cr614 Cr172 Cr180 Cr270 Cr
Tax %16.1%17.0%19.1%16.8%17.3%19.1%19.7%16.0%15.6%12.0%-49.6%23.5%
Net profit369 Cr213 Cr386 Cr669 Cr677 Cr132 Cr406 Cr480 Cr518 Cr151 Cr269 Cr207 Cr
EPS (₹)₹20.60₹11.88₹21.56₹37.32₹37.81₹7.43₹22.70₹26.84₹28.94₹8.46₹14.96₹11.53

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales2,095 Cr1,915 Cr2,052 Cr1,945 Cr2,707 Cr3,999 Cr4,430 Cr4,078 CrSign in for TTM
Operating expenses (approx.)1,300 Cr1,332 Cr1,446 Cr1,681 Cr1,772 Cr2,247 Cr2,234 Cr2,642 CrSign in for TTM
EBITDA795 Cr583 Cr606 Cr264 Cr936 Cr1,751 Cr2,196 Cr1,437 CrSign in for TTM
OPM %37.9%30.4%29.5%13.5%34.6%43.8%49.6%35.2%Sign in for TTM
Other income130 Cr107 Cr104 Cr99 Cr105 Cr128 Cr355 Cr298 CrSign in for TTM
Interest19 Cr22 Cr13 Cr18 Cr15 Cr19 Cr24 Cr37 CrSign in for TTM
Depreciation81 Cr100 Cr117 Cr143 Cr164 Cr187 Cr235 Cr207 CrSign in for TTM
Profit before tax825 Cr569 Cr580 Cr202 Cr862 Cr1,674 Cr2,291 Cr1,537 CrSign in for TTM
Tax %22.1%19.4%23.7%15.9%17.0%17.0%17.8%7.7%Sign in for TTM
Net profit642 Cr458 Cr442 Cr170 Cr715 Cr1,388 Cr1,883 Cr1,419 CrSign in for TTM
EPS (₹)₹34.98₹25.33₹24.20₹9.32₹39.18₹77.34₹105.26₹79.20Sign in for TTM
Dividend payout %———48.4%14.0%12.3%5.7%6.4%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital37 Cr36 Cr37 Cr37 Cr37 Cr36 Cr36 Cr36 Cr
Reserves3,453 Cr3,737 Cr4,085 Cr4,227 Cr4,837 Cr5,817 Cr7,571 Cr9,185 Cr
Borrowings386 Cr316 Cr268 Cr—165 Cr363 Cr273 Cr706 Cr
Other liabilities426 Cr487 Cr401 Cr846 Cr619 Cr690 Cr745 Cr1,146 Cr
Total liabilities4,303 Cr4,588 Cr4,792 Cr5,109 Cr5,657 Cr6,906 Cr8,631 Cr11,074 Cr
Fixed assets (net)1,219 Cr1,576 Cr2,014 Cr—2,239 Cr2,298 Cr2,432 Cr2,545 Cr
CWIP638 Cr518 Cr223 Cr—64 Cr137 Cr225 Cr294 Cr
Investments169 Cr112 Cr304 Cr—392 Cr539 Cr474 Cr3,127 Cr
Loans & advances7 Cr8 Cr13 Cr—10 Cr9 Cr9 Cr10 Cr
Inventories529 Cr558 Cr798 Cr—743 Cr701 Cr766 Cr909 Cr
Trade receivables506 Cr551 Cr413 Cr—856 Cr1,189 Cr1,247 Cr881 Cr
Cash & bank28 Cr20 Cr26 Cr—132 Cr70 Cr120 Cr199 Cr
Other assets1,208 Cr1,244 Cr1,001 Cr5,109 Cr1,221 Cr1,963 Cr3,358 Cr3,109 Cr
Total assets4,303 Cr4,588 Cr4,792 Cr5,109 Cr5,657 Cr6,906 Cr8,631 Cr11,074 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity———47 Cr849 Cr1,212 Cr1,697 Cr1,768 Cr
Cash from investing———-5 Cr-477 Cr-1,033 Cr-1,414 Cr-2,143 Cr
Cash from financing———35 Cr-363 Cr-247 Cr-211 Cr298 Cr
Net cash flow———85 Cr21 Cr-61 Cr50 Cr79 Cr
Free cash flow (OCF − Capex)———-196 Cr644 Cr853 Cr1,185 Cr1,377 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2019BSE balance sheet (this exchange's own filing had none for this period)Mar 2020BSE balance sheet (this exchange's own filing had none for this period)Mar 2021BSE balance sheet (this exchange's own filing had none for this period)Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %24.2%15.6%13.5%5.2%17.4%27.2%29.4%15.9%
ROE %18.5%12.2%11.7%4.0%14.7%23.7%24.8%15.4%
Debtor days8810573—11510910279
Inventory days578619779—569489520557
Days payable237283143—202165187251
Cash conversion cycle429441710—482433436385
Debt / equity0.110.080.06—0.030.060.040.08
Current ratio3.223.394.45—4.394.145.593.01
Net debt / EBITDA0.000.000.000.000.040.170.070.35

Compare with peers

Loading peers…